| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") today annou...
Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why.
Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the po...
Venture capitalist Chamath Palihapitiya, once dubbed the "SPAC King," is returning to Wall Street with a new blank-chec...
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and lowers the price target from ...